glypican-3 Antibodies

Santa Cruz Biotechnology features a diverse variety of glypican-3 monoclonal antibodies for research in understanding glypican-3's role in various biological processes. glypican-3 Antibodies are validated for multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glypican-3 is a heparan sulfate proteoglycan with essential functions in cell growth, differentiation, and signaling pathway regulation. Research has shown glypican-3's significance in cancer development, particularly in tumor growth and metastasis, establishing it as a potential biomarker and therapeutic target in various malignancies. Investigating glypican-3 functions continues to reveal important insights into developmental processes and disease mechanisms. Glypican-3 expression patterns can be effectively studied using specific conjugates, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC). Advanced research techniques help uncover new aspects of glypican-3's biological significance and potential therapeutic applications. Current studies focus on understanding glypican-3's role in cellular signaling and its impact on disease progression. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of glypican-3's role in human health and disease.